Join Craig Mooney, Calyx’s Scientific eTech Enabled Services VP and Sylvain Berthelot, Calyx’s Technical Solutions Consultant from 1:30 am – 2:30 am in their Clinical Supplies Unblinding Risk Assesments Workshop on Monday, April 24th and 10:00 am- 11:00 am on Tuesday, April 25th.
There are so many ways we can unblind our clinical trials. This workshop will discuss many of the different ways our clinical supply chain can contribute to unblinding. These can include differences in packaging configuration between arms in a trial, shipping to a clinical site with documents that could unblind the trial or IRT challenges that lead to unblinding.
Hyatt Regency Grand Cypress Resort
Vice President, Scientific E-tech Enabled Services, Calyx
Craig Mooney has nearly 30 years’ experience in the clinical development industry, with concentrated focus on optimizing IRT to improve clinical trial efficiencies. Craig brings a unique understanding of IRT from both a delivery and user perspective, having served as the Director of IRT at Bristol-Myers Squibb for most of the past decade and having held roles in clinical operations, IMP packaging, and labeling & logistics. He is considered an industry expert and has been a featured speaker at numerous IRT conferences including positions as Conference Chairman.
Sr. Dir. Voice of Customer & Strategy
Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.